Description

Cyclo(Cysteinyl-Tyrosyl-Norleucyl-Glycyl-Tryptophyl-Cysteinyl)-Aspartyl-Phenylalaninamide is a synthetic cyclic peptide of significant interest in advanced biochemical research and pharmaceutical development. This compound matters due to its complex structure, which is engineered to mimic or interfere with specific biological pathways, making it a valuable tool for studying peptide-receptor interactions and metabolic processes. It is primarily needed by research institutions, biotechnology companies, and pharmaceutical developers focused on endocrinology, oncology, and metabolic disease research.

Application

• Biochemical Research: Used as a reference standard or active probe in studies of peptide hormone activity, receptor binding assays, and signal transduction pathways.
• Pharmaceutical R&D: Serves as a key intermediate or lead compound in the development of novel therapeutic agents targeting G-protein-coupled receptors (GPCRs).
• Endocrinology Studies: Applied in metabolic research to investigate the role of peptide analogs in hormone regulation and related disorders.
• Oncology Research: Explored for its potential in modulating cell proliferation and apoptosis in cancer cell line studies.
• Peptide Library Synthesis: Acts as a structurally complex component in the creation of specialized peptide libraries for high-throughput screening.
• Academic Research: Utilized in university and institutional labs for teaching and advanced research in peptide chemistry and molecular biology.

Basic Information

Product Name	Cyclo(Cysteinyl-Tyrosyl-Norleucyl-Glycyl-Tryptophyl-Cysteinyl)-Aspartyl-Phenylalaninamide
CAS No.	111897-98-4
Molecular Formula	C58H73N13O13S2
Molecular Weight	1216.4 g/mol
Synonyms	Cyclo(Cys-Tyr-Nle-Gly-Trp-Cys)-Asp-Phe-NH2; Cyclic Cys-Tyr-Nle-Gly-Trp-Cys-Asp-Phe amide; Somatostatin cyclic peptide analog; c[Cys-Tyr-Nle-Gly-Trp-Cys]-Asp-Phe-NH2; 111897-98-4; Cyclo(CTNleGWCD)-F-NH2; Cyclic octapeptide 111897-98-4
EINECS	Contact for details

Quality Control

Our Cyclo(Cysteinyl-Tyrosyl-Norleucyl-Glycyl-Tryptophyl-Cysteinyl)-Aspartyl-Phenylalaninamide is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, MS for identity confirmation, and chiral analysis to ensure structural integrity. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications and test results. Our quality commitment aligns with cGMP principles for active pharmaceutical ingredients (APIs) and research-grade biochemicals.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below for long-term stability. This product is hygroscopic (moisture-sensitive). Allow the vial to reach room temperature in a desiccator before opening to minimize moisture uptake. For short-term use, store at 2-8°C.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/MS)	Conforms to reference standard
Purity (HPLC)	≥ 95.0%
Single Impurity (HPLC)	≤ 2.0%
Water Content (KF)	≤ 5.0%
Peptide Content	≥ 80.0%
Solubility	Soluble in DMSO, Acetic Acid; Sparingly soluble in Water

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.